Rating: HOLD
HOLD (5-tier) · cyclical compounder · conviction: medium
| Metric | Value |
|---|---|
| Current Price | $293 |
| Triangulated Fair Value | $243 (-17% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $280 (-5% vs spot · 12m PWEV) |
| Forward P/E | 41.0x |
| Market Cap | $293B |
| 52-Week Range | $151–$334 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-27. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Investment Committee Summary
| Rating | HOLD · HOLD (5-tier) |
| Classification · conviction | cyclical compounder · medium |
| Triangulated fair value | $243 (-17% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $280 (-5% vs spot · 12m PWEV) |
| Next catalyst | 2026-02-10 — Capital-management / capex framework update (analyst day cadence) |
| Primary thesis-break | Quarterly revenue year-on-year growth < -3% (midpoint of Cyclical -3% and Base 10% recovery paths, on a YoY basis) (2 consecutive prints) |
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies -5% vs spot
- Monte Carlo median implies -12% vs spot
- DCF fair value implies -19% vs spot — but this is terminal-value sensitive (exit-multiple $237 vs Gordon $122, 49% apart), so it carries less weight
- Bear case (Structural — AI-Capex Digestion / China / Export Controls) downside is -54% vs spot
- Net: reward/risk of 0.3× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Investment Thesis
At the 2026-06-27 spot of $298.07 on roughly 41x forward earnings, the market is paying a durable quality premium for TXN's analog/embedded franchise and its US-based 300mm fab build, pricing a clean mid-cycle recovery. The engine is less generous. Its probability-weighted target of $286.40 sits marginally below spot, so the rating is HOLD. The independent DCF anchors lower still: $216 on a 30x terminal, $112 on a Gordon terminal, because the capex-bridge charges $4.55B of FY2025 capex against only $2.0B of D&A and treats much of the build as not yet earning its cost of capital. That capex-versus-return gap, not near-term demand, is where the engine diverges from the tape. Peer forward multiples reinforce the caution: NVDA at 23x and MU near 11x make TXN's 41x look expensive for 10% modelled growth. The single most damaging risk is that the new fabs stay underutilised, so fixed-cost deleverage holds gross margin down while the multiple de-rates toward the deep-cyclical floor.
The dashboard below is the whole argument on one page: spot ($293) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The strongest bear case is the Semi Downturn state, which the cluster house view weights most heavily. AI-capex digestion and export-control loss of China demand remove a structural slice of the addressable market just as TXN carries the depreciation and interest load of a multi-year 300mm build. Utilisation on the new fabs stays low, fixed-cost deleverage drags gross margin below 55%, and operating margin compresses toward the mid-30s. With roughly 79% of target variance attributable to the multiple, the market strips the quality premium and re-rates the franchise toward a deep-cyclical 30x. Earnings and the multiple fall together, and the target settles below the 52-week low of $150.97.
Key Debate
P/E Multiple explains 79% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.36 vs analyst floor +0.00 → delta +0.36 (n=43 mgmt / 18 Q&A; 45th pctile across the S&P book, z -0.2).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.36 | +0.00 | +0.36 |
| 2025Q4 | +0.38 | +0.33 | +0.05 |
| 2025Q3 | +0.22 | +0.03 | +0.19 |
| 2025Q2 | +0.19 | +0.01 | +0.18 |
News (last 365d, 1000 articles): avg ticker sentiment +0.18 (bullish 22% / bearish 3%)
Scenario Analysis
The tree runs from a structural 'Structural — AI-Capex Digestion / China / Export Controls' downside ($135) to a 'Bull — Supercycle Re-Rate' bull case ($487); the probability-weighted blend (PWEV $280) is -5% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — AI-Capex Digestion / China / Export Controls | 20% | $135 | -54% |
| Cyclical Downturn — Inventory Correction | 17% | $214 | -27% |
| Base — Mid-Cycle + AI Content | 35% | $290 | -1% |
| Upcycle — AI / Datacenter Demand | 20% | $380 | +30% |
| Bull — Supercycle Re-Rate | 8% | $487 | +66% |
| Probability-Weighted (PWEV) | — | $280 | -5% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — AI-Capex Digestion / China / Export Controls (20%, $135). Structural impairment — AI-capex digestion / China / export controls: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 126.02; probability: 0.2.
- Cyclical Downturn — Inventory Correction (17%, $214). Cyclical downturn — chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls weakens for 1–2 years before normalising. Drivers — implied_target: 214.0; probability: 0.17.
- Base — Mid-Cycle + AI Content (35%, $290). Mid-cycle — normalised chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls; disciplined capital allocation; steady returns. Drivers — implied_target: 297.22; probability: 0.35.
- Upcycle — AI / Datacenter Demand (20%, $380). Upside — AI + datacenter demand supercycle lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 401.25; probability: 0.2.
- Bull — Supercycle Re-Rate (8%, $487). Upside tail — sustained tight conditions or a structural re-rate on AI + datacenter demand supercycle. Drivers — implied_target: 506.76; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $257 | -12% |
| Peer P/E re-rate | multiple | $147 | -50% |
| Peer EV/Revenue re-rate | multiple | $300 | +2% |
| Scenario PWEV | multiple | $280 | -5% |
| DCF (5-year + terminal) | cash flow + terminal × | $237 | -19% |
| Triangulated (weighted) | — | $243 | -17% |
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $257 + scenario PWEV $280, ≈ spot); the weighted blend $243 (-17%) sits below it because the cash-flow DCF ($237) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $257 and 38% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (79% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 10.0%, 30x terminal FCF multiple → $237. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 20.53x) implies $147. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is 60% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Semiconductors | $18.4B | 100% | 10% | 42% | $7.6B | 40x | 10% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls |
| net_debt_or_cash_b | -10.5 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.1 |
| div_yield | 0.0183 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | AI-capex digestion / China / export controls |
| upside | AI + datacenter demand supercycle |
Industry Context — Information Technology — Semis
This name sits in the Information Technology — Semis as a semiconductors. chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: AVGO (semiconductors) · AMD (semiconductors) · INTC (semiconductors) · AMAT (semi_equipment) · KLAC (semi_equipment) · TXN (semiconductors) · MRVL (semiconductors) · QCOM (semiconductors) · ADI (semiconductors) · NXPI (semiconductors) · MPWR (semiconductors) · TER (semi_equipment) · MCHP (semiconductors) · ON (semiconductors) · Q (semi_equipment) · SWKS (semiconductors)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Semi Downturn — AI-Capex Digestion / China | 37% | 37% | |
| Mid-Cycle — Normalised + AI Content | 35% | 35% | |
| Upcycle — AI / Datacenter Supercycle | 28% | 28% |
Mapping note: name-level 'Structural — AI-Capex Digestion / China / Export Controls' (20%) + 'Cyclical Downturn — Inventory Correction' (17%) map to cluster Semi Downturn — AI-Capex Digestion / China (37%); name-level 'Upcycle — AI / Datacenter Demand' (20%) + 'Bull — Supercycle Re-Rate' (8%) map to cluster Upcycle — AI / Datacenter Supercycle (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.
On the cluster's key downside — Semi Downturn — AI-Capex Digestion / China () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The it_semis cycle is the shared macro driver. Driver — chip demand (AI/datacenter, auto, mobile) + semi cycle + WFE capex + China/export controls Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $20B | $9B | $4B | $5B | $8B | $7B |
| FY+2 | $22B | $10B | $4B | $4B | $9B | $7B |
| FY+3 | $24B | $11B | $4B | $4B | $10B | $8B |
| FY+4 | $25B | $12B | $4B | $4B | $11B | $7B |
| FY+5 | $27B | $13B | $3B | $4B | $11B | $7B |
| Terminal | — | — | — | — | $11B × 30x | $211B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 10% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 10.0% · Σ PV(FCF) $36B + PV(terminal) $211B = EV $247B; + net cash → equity $237B ÷ diluted shares 1.00B = $237/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $122/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 15% vs WACC 10% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| NVDA | 18.75x | 22.68x | 10% | 66% |
| AVGO | 24.69x | 33.0x | 10% | 49% |
| MU | 14.96x | 10.54x | 10% | 68% |
| QCOM | 4.8x | 18.38x | 10% | 22% |
| Median | 16.855x | 20.53x | — | — |
Peer-median fwd P/E → $147; EV/Rev → $300.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $237 | 41% | $98 |
| Scenario PWEV | $280 | 29% | $82 |
| Monte Carlo median | $257 | 18% | $45 |
| Peer P/E | $147 | 12% | $17 |
| Triangulated | — | 100% | $243 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 21.0x | 25.5x | 30.0x | 34.5x | 39.0x |
|---|---|---|---|---|---|
| 8% | $190 | $225 | $260 | $294 | $329 |
| 9% | $182 | $215 | $248 | $281 | $314 |
| 10% | $174 | $205 | $237 | $269 | $301 |
| 11% | $166 | $197 | $227 | $257 | $287 |
| 12% | $159 | $188 | $217 | $246 | $275 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $195 | $202 | $208 | $215 | $221 |
| -1.5pp | $208 | $215 | $222 | $229 | $236 |
| +0.0pp | $222 | $230 | $237 | $245 | $252 |
| +1.5pp | $237 | $245 | $253 | $261 | $269 |
| +3.0pp | $252 | $261 | $269 | $278 | $286 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Terminal × ±15% | $205 | $269 | $63 |
| Revenue CAGR ±3pp | $208 | $269 | $61 |
| Op margin ±3pp | $222 | $252 | $30 |
| Capex intensity ±15% | $226 | $249 | $23 |
| WACC ±1pp | $227 | $248 | $21 |
Company lever — SoP/share vs Semiconductors multiple (AI re-rating) (base 40x)
| Multiple | 28.0x | 34.0x | 40.0x | 46.0x | 52.0x |
|---|---|---|---|---|---|
| SoP/share | $508 | $619 | $730 | $841 | $952 |
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $298 (+2% vs spot · street) |
| House target | $286 (-3.9% vs street) |
| Sell-side coverage | 37 analysts (SB 2 / B 15 / H 18 / S 2 / SS 0; net score 0.23) |
| Consensus FY EPS | $8.95; house below (-20.0%) |
| Consensus FY revenue | $23.3B; house below (-13.0%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $10.5B — modestly levered |
| Net debt / EBITDA | 1.21x |
| Interest coverage (EBIT / interest) | 11.5x |
| Current ratio | 4.35x |
| Cash & ST investments | $4.9B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $2.6B |
| Buybacks / dividends | $1.5B / $5.0B |
| Total shareholder yield | 2.2% |
| Payout as % of FCF | 248.8% |
| Reinvestment (capex / OCF) | 63.6% |
| SBC as % of FCF | 16.1% |
| Allocation stance | returning more than FCF (balance-sheet funded) |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 14.1% |
| FCF conversion (FCF / net income) | 52.0% |
| FCF yield | 0.9% |
| Capex intensity (capex / revenue) | 24.7% |
| FCF − SBC (diagnostic) | $2.2B |
| Capex split (maint / growth) | 25% / 75% — Heavy builder: ~10% capex/rev in a multi-year 300mm fab expansion far above D&A; the growth tilt is the source of the FCF/ROIC dilution the engine flags. |
Accounting quality: SBC 2.3% of revenue; cash conversion (OCF/NI) 143% — cash-backed.
Catalyst Calendar
- 2026-02-10 (~-148d) — Capital-management / capex framework update (analyst day cadence) (authored)
- 2026-07-22 (~14d) — Quarterly earnings — est. EPS $1.90 (AV EARNINGS_CALENDAR)
- 2026-07-31 (~23d) — SM1/LFAB 300mm fab utilisation ramp checkpoint (authored)
- 2027-01-31 (~207d) — CHIPS Act incentive / ITC realization milestone (authored)
Forecast Track Record
- EPS surprise: beat 75.0% of the last 8 quarters; average surprise +8.3%.
Competitive Moat
Wide moat. The moat is genuinely wide — an unmatched analog/embedded catalog (~80k+ parts), owned 300mm US fabs (lowest unit cost), direct sales/distribution reach and decades-long design-in stickiness — which justifies a premium terminal multiple ABOVE the market. But at ~40x the capex-bridge shows $4.55B FY25 capex against only ~$2.0B D&A, so the multiple is hostage to fab utilisation, not moat quality. Falsifiable: if new-fab utilisation stays low and gross margin holds below 55% through the cycle, incremental returns fail cost of capital and even a wide moat cannot support 40x — it should compress toward high-20s/30x.
Moat sources:
- Broadest analog/embedded product catalog with long design-in lifecycles (auto/industrial sockets)
- Owned 300mm US wafer fabs = structural unit-cost advantage vs fabless/foundry peers
- Direct sales + largest catalog distribution reach (TI.com) — proprietary channel
- In-house manufacturing + geographic diversification (US CHIPS-supported build)
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| US-China export controls / China analog demand loss and domestic-substitution acceleration | high (~55%) | high - China is a material end-market; structural share loss ~10-15% of FV | 12-24m |
| CHIPS Act incentive execution / tariff regime on semiconductors (net could be positive) | medium (~50%) | medium - incentive timing swings FCF/ROIC on the build ~5-8% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — AI-Capex Digestion / China / Export Controls | AI-capex digestion plus export-control-driven loss of China demand removes a structural slice of the addressable analog market. | Low new-fab utilisation carries full depreciation/interest load — fixed-cost deleverage pushes gross margin below 55% and compresses earnings AND multiple. |
| Cyclical Downturn — Inventory Correction | Broad-based semiconductor inventory correction (auto/industrial/mobile) softens demand for 1-2 years before normalising. | The capex ramp continues into a demand trough, so FCF is thin exactly when utilisation falls. |
| Base — Mid-Cycle + AI Content | Mid-cycle analog demand recovery with rising AI/datacenter analog content; disciplined capital returns. | Even mid-cycle, the $4.55B capex vs ~$2.0B D&A gap keeps DCF fair value well below a 40x tape. |
| Upcycle — AI / Datacenter Demand | AI/datacenter and broad-industrial upcycle lifts analog content and fab utilisation above trend. | Requires the new 300mm capacity to fill quickly — utilisation timing is the load-bearing variable. |
| Bull — Supercycle Re-Rate | Analog supercycle with sustained pricing and US-manufacturing scarcity premium re-rates the franchise. | Prices a durable supercycle and full-utilisation payoff on the build the current capex-bridge does not credit. |
What the Market Is Pricing In
At the current price, the market pays 32.8× forward EPS, vs the house DCF terminal 30.0×, and a peer median 20.53×. The house DCF sits 19% below spot, so the market is pricing in more than the house case — roughly 2.2pp of revenue CAGR.
Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 23.3 | 20.3 | High |
| EPS | 8.9 | 7.2 | Medium |
| Target price | 298.0 | 286.4 | Medium |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| NVDA | 22.68× | 10% | 66% | segment | 50% |
| AVGO | 33.0× | 10% | 49% | direct | 100% |
| MU | 10.54× | 10% | 68% | broad | 25% |
| QCOM | 18.38× | 10% | 22% | segment | 50% |
Quality-weighted forward P/E: 25.0× (simple median 20.53×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $151–$334, centre $225 (-23% vs spot); spot sits at the 78th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $243 (-17% vs spot · triangulated FV) |
| Downside to bear case (Structural — AI-Capex Digestion / China / Export Controls) | $135 (-54% vs spot · bear scenario) |
| Reward/risk ratio | 0.3× |
| Margin of safety (FV vs spot) | -21% |
| P(price > spot) — Monte Carlo | 38% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Supercycle Re-Rate): $487.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 10.0% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 30× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Terminal × ±15% (63.0); Revenue CAGR ±3pp (61.0); Op margin ±3pp (30.0); Capex intensity ±15% (23.0); WACC ±1pp (21.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $18.4B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $20.3B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $8.948 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.999B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $10.51B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 10.0% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 30× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-07-08 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-06-27 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-07-08 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-07-08 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-07-08 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-07-08 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-07-08 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-07-08 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-07-08 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Load-Bearing Assumptions
DCF: WACC 10%, terminal multiple 30×, FY+5 revenue $27B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Quarterly revenue year-on-year growth < -3% (midpoint of Cyclical -3% and Base 10% recovery paths, on a YoY basis) (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). Two straight quarters of YoY revenue decline signal the inventory correction is deepening past a one-quarter dip toward the Cyclical or Structural path, invalidating the Base recovery assumption.
- Gross margin < 55% (well below the ~58-60% mid-cycle level; the new-fab deleverage line) (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). Sustained sub-55% gross margin would confirm fixed-cost deleverage on the underutilised 300mm fabs is structural, pointing at the compressed operating-margin assumption in the Structural path rather than a transient trough.
- Fab utilisation / free-cash-flow per share < $5.00 FCF/share trailing-twelve-month (against the historically higher pre-build level) (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). If elevated capex ($4.55B FY2025 against $2.0B D&A) does not convert to rising cash generation, the fab build is value-dilutive and the DCF capex-bridge penalty deepens, undermining the Base target.
- China revenue contribution or an incremental US export-control action affecting analog/embedded shipments >= a new binding restriction or China revenue falling below the low-teens percent of total (single event → Semi Downturn — AI-Capex Digestion / China). A discrete tightening of export controls or a step-loss of China demand would remove a structural slice of the addressable market, moving weight from the Cyclical path toward the Structural path.
- Forward P/E multiple < 33x (the Cyclical-path multiple, versus the ~41x Base premium) (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). The Monte Carlo attributes ~79% of target variance to the multiple. A durable de-rating below the mid-cyclical 33x line signals the market has abandoned the quality premium embedded in the Base and higher scenarios.
Fact / Inference / Speculation
- FACT: Spot $293; 52-week range $151–$334; engine rating HOLD; base-case target $286 (-2%). (source: Alpha Vantage 2026-06-27, 8 July 2026)
- INFERENCE: Triangulated FV $243 (-17% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Recommendation: HOLD
Balanced: triangulated fair value $243 (-17% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.